Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Tela Bio Inc (TELA)

Tela Bio Inc (TELA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 244,894
  • Shares Outstanding, K 14,414
  • Annual Sales, $ 15,450 K
  • Annual Income, $ -22,430 K
  • 60-Month Beta N/A
  • Price/Sales 15.71
  • Price/Cash Flow N/A
  • Price/Book 3.03
Trade TELA with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.50
  • Number of Estimates 2
  • High Estimate -0.38
  • Low Estimate -0.62
  • Prior Year -22.58
  • Growth Rate Est. (year over year) +97.79%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.59 +16.45%
on 09/24/20
17.19 -1.16%
on 10/23/20
+1.38 (+8.84%)
since 09/23/20
3-Month
11.50 +47.74%
on 07/31/20
17.57 -3.30%
on 09/14/20
+3.11 (+22.41%)
since 07/23/20

Most Recent Stories

More News
Hercules Capital Reports Fourth Quarter and Record Full-Year 2019 Financial Results

--Record FY2019 New Debt and Equity Commitments of $1.47 Billion, up 21.6% Year-over-Year

TELA : 16.99 (+0.95%)
MYOV : 15.82 (+2.33%)
UROV : 8.26 (+1.35%)
HTGC : 11.45 (-0.69%)
HCXZ : 25.35 (+0.18%)
HCXY : 26.40 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

TELA Bio Inc. is a commercial stage medical technology company. It is focused on the designing, developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company offers a portfolio of advanced reinforced tissue matrices. TELA Bio Inc. is headquartered...

See More

Key Turning Points

2nd Resistance Point 17.30
1st Resistance Point 17.15
Last Price 16.99
1st Support Level 16.88
2nd Support Level 16.76

See More

52-Week High 23.55
Last Price 16.99
Fibonacci 61.8% 16.56
Fibonacci 50% 14.40
Fibonacci 38.2% 12.24
52-Week Low 5.25

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar